SM1 5mg (Semaglutide 5mg) — GLP-1 Receptor Agonist

Native GLP-1 lasts about two minutes in circulation before DPP-IV enzymes chew it apart. SM1 (Semaglutide 5mg) was engineered to survive. This 31-amino-acid analog carries a C18 fatty acid chain that lets it hitch a ride on serum albumin — a molecular trick that extends its functional half-life dramatically in experimental models while preserving full GLP-1 receptor affinity.

The engineering behind it

Two problems had to be solved. First, resistance to DPP-IV cleavage — the enzyme that makes native GLP-1 nearly useless as a research tool due to its rapid degradation. Second, a way to extend circulation time without altering receptor binding. The C18 fatty acid acylation addresses both: it provides steric protection from enzymatic degradation and enables reversible, non-covalent albumin association that keeps the peptide in circulation far longer than the native hormone.

The receptor interaction itself is well-characterized. SM1 (Semaglutide 5mg) activates GLP-1 receptors on pancreatic beta cells, initiating a cAMP/PKA signaling cascade that drives glucose-dependent insulin secretion. The key phrase is glucose-dependent — GLP-1 receptor agonists work with existing glucose levels rather than forcing insulin release regardless of metabolic state.

Specifications

Amino Acids	31
Classification	Selective GLP-1 receptor agonist
Modification	C18 fatty acid acylation for albumin binding
Form	Lyophilized powder
Quantity	5mg per vial

What the research shows

Hypothalamic appetite regulation

GLP-1 receptors are expressed in the arcuate nucleus and other appetite-regulating brain regions. Preclinical studies have examined how receptor agonism at these central sites modulates feeding behavior and energy balance through both peripheral and central signaling pathways.

Metabolic pathway studies

Research models have examined GLP-1 receptor activation in the context of glucose homeostasis, insulin sensitivity, hepatic glucose output, and overall energy balance as part of the broader incretin signaling axis.

Semaglutide 5mg is Frequently paired with

Cagrilintide 5mg — Amylin analog. Amylin and GLP-1 act through distinct neuronal circuits (hindbrain vs hypothalamic), making them complementary research targets.
AOD-9604 5mg — HGH Fragment 176-191 for comparative metabolic research.
MOTS-C 10mg — AMPK pathway activation and cellular energy metabolism.

Buy now online from Peptide Bio Sciences LTD.